Valuation: Celltrion Pharm, Inc.

Market Cap 4,674B 6,949,766B 4,084B 3,769B 3,474B 6,548B 450,083B 6,693B 45,048B 17,718B 220,432B 17,552B 17,167B 758,833B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 7,192,554B 4,227B 3,901B 3,595B 6,777B 465,806B 6,927B 46,622B 18,337B 228,133B 18,165B 17,767B 785,343B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.4%
Yield 2019 *
-
Yield 2020 -
1 day-0.75%
1 week-2.93%
Current month-2.69%
1 month-10.66%
3 months-31.97%
6 months-35.60%
Current year-31.38%
1 week 39,200
Extreme 39200
42,350
1 month 38,950
Extreme 38950
43,550
Current year 38,950
Extreme 38950
78,300
1 year 38,950
Extreme 38950
78,300
3 years 38,950
Extreme 38950
124,463.12
5 years 38,950
Extreme 38950
146,932.97
10 years 13,660.97
Extreme 13660.9749
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 25/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 52 -
Director TitleAgeSince
Chairman 68 27/03/2025
Director/Board Member 77 27/03/2023
Director/Board Member 65 25/03/2021
Date Insider Type Main position Quantity % Market Cap.
07/05/25 Others 127 0.0003%
07/05/25 Fiscal year 4,500 0.0103%
07/05/25 Others 24 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-2.93%-25.37%-48.56% 1.18B
-0.90%-0.15%+13.46%+79.34% 48.15B
-0.23%-1.65%+65.14%+115.81% 35.59B
-0.76%-1.44%-4.30%+37.38% 11.9B
-0.88%-0.62%+16.38%+89.65% 11.85B
+0.19%+2.87%+34.92%+127.54% 9.31B
-0.75%-0.91%+18.26%+37.23% 6.91B
-9.93%+0.35%-29.90%+14.89% 6.13B
+3.37%-0.10%+49.31%-4.38% 7.02B
-2.25%-2.08%+0.40%+218.27% 6.55B
Average -1.29%-0.24%+13.83%+66.72% 14.46B
Weighted average by Cap. -0.88%-0.44%+25.56%+85.25%

Financials

2019 2020
Net sales 174B 258,014B 152B 140B 129B 243B 16,710B 248B 1,672B 658B 8,184B 652B 637B 28,172B 234B 347,316B 204B 188B 174B 327B 22,493B 334B 2,251B 885B 11,016B 877B 858B 37,923B
Net income 8.6B 12,791B 7.52B 6.94B 6.39B 12.05B 828B 12.32B 82.91B 32.61B 406B 32.31B 31.6B 1,397B 20.94B 31,137B 18.3B 16.89B 15.56B 29.34B 2,017B 29.99B 202B 79.38B 988B 78.64B 76.91B 3,400B
Net Debt 149B 220,899B 130B 120B 110B 208B 14,306B 213B 1,432B 563B 7,006B 558B 546B 24,120B 163B 242,788B 143B 132B 121B 229B 15,724B 234B 1,574B 619B 7,701B 613B 600B 26,510B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
16/07/26 ₩39,800.00 -0.75% 82,166
15/07/26 ₩40,100.00 +1.01% 62,155
14/07/26 ₩39,700.00 -1.37% 96,578
13/07/26 ₩40,250.00 -1.83% 85,057
10/07/26 ₩41,000.00 +1.74% 78,861
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock